Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean P Gavan

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
International Journal of Technology Assessment in Health Care|June 2, 2025
Supporting translation with early health technology assessment: from definition to actionSean P Gavan
The Lancet. Rheumatology|November 4, 2024
Digital remote monitoring in rheumatology: using health economics to support wider adoptionSean P Gavan
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 5, 2026
Rescaled Value Set Regressions: Making the Nonparametric Crosswalk between EQ-5D-5L and EQ-5D-3L more TransparentSean P Gavan
Health Economics Review|February 17, 2026
Value of information analyses for advanced cell therapies: a systematic reviewAlexander Heaps, Sean P Gavan
International Journal of Technology Assessment in Health Care|July 29, 2025
Constraints on delivering cell and gene therapies identified during technology appraisal by the National Institute for Health and Care ExcellenceHarshini Hariram, Sean P Gavan
Handbook of Experimental Pharmacology|June 29, 2022
Economics and Precision MedicineKatherine Payne, Sean P Gavan
Rheumatology Advances in Practice|April 8, 2024
Overcoming provider barriers to therapeutic drug monitoring of tumour necrosis factor inhibitors for rheumatoid arthritis: a qualitative analysisSean P Gavan, Katherine Payne, Anne Barton
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 25, 2022
Valuing Health Gain from Composite Response Endpoints for Multisystem DiseasesSean P Gavan, Ian N Bruce, Katherine Payne, et al.
Expert Review of Precision Medicine and Drug Development|April 24, 2018
The economic case for precision medicineSean P Gavan, Alexander J Thompson, Katherine Payne
Journal of Personalized Medicine|May 24, 2019
Assessing the Joint Value of Genomic-Based Diagnostic Tests and Gene TherapiesSean P Gavan, Christine Y Lu, Katherine Payne
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
International Journal of Technology Assessment in Health Care|June 2, 2025
Supporting translation with early health technology assessment: from definition to actionSean P Gavan
The Lancet. Rheumatology|November 4, 2024
Digital remote monitoring in rheumatology: using health economics to support wider adoptionSean P Gavan
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 5, 2026
Rescaled Value Set Regressions: Making the Nonparametric Crosswalk between EQ-5D-5L and EQ-5D-3L more TransparentSean P Gavan
Health Economics Review|February 17, 2026
Value of information analyses for advanced cell therapies: a systematic reviewAlexander Heaps, Sean P Gavan
International Journal of Technology Assessment in Health Care|July 29, 2025
Constraints on delivering cell and gene therapies identified during technology appraisal by the National Institute for Health and Care ExcellenceHarshini Hariram, Sean P Gavan
Handbook of Experimental Pharmacology|June 29, 2022
Economics and Precision MedicineKatherine Payne, Sean P Gavan
Rheumatology Advances in Practice|April 8, 2024
Overcoming provider barriers to therapeutic drug monitoring of tumour necrosis factor inhibitors for rheumatoid arthritis: a qualitative analysisSean P Gavan, Katherine Payne, Anne Barton
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 25, 2022
Valuing Health Gain from Composite Response Endpoints for Multisystem DiseasesSean P Gavan, Ian N Bruce, Katherine Payne, et al.
Expert Review of Precision Medicine and Drug Development|April 24, 2018
The economic case for precision medicineSean P Gavan, Alexander J Thompson, Katherine Payne
Journal of Personalized Medicine|May 24, 2019
Assessing the Joint Value of Genomic-Based Diagnostic Tests and Gene TherapiesSean P Gavan, Christine Y Lu, Katherine Payne
Pageof 4